Galapagos NV
GLPG
#4872
Rank
A$2.70 B
Marketcap
A$40.22
Share price
-1.58%
Change (1 day)
1.00%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): A-$0.71

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.48. In 2024 the company made an earnings per share (EPS) of A$1.63 a decrease over its 2023 EPS that were of A$4.98.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.71-143.17%
2024A$1.63-67.16%
2023A$4.98-199.64%
2022A-$4.9999.03%
2021A-$2.51-68.98%
2020A-$8.09-298.06%
2019A$4.08-554.64%
2018A-$0.90-77.18%
2017A-$3.94-326.21%
2016A$1.74-134.19%
2015A-$5.09-371.34%
2014A$1.88-445.98%
2013A-$0.5432.88%
2012A-$0.41-82.07%
2011A-$2.28-817.9%
2010A$0.3212.73%
2009A$0.28-120.79%
2008A-$1.35-37.67%
2007A-$2.1739.64%
2006A-$1.5528.17%
2005A-$1.216.25%
2004A-$1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.62-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.26-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$3.35-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.90-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.25-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$8.32-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$5.28-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A-$0.86 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.74-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel